Chemopreventive approach of Indian spice “Curcumin” in the treatment of breast cancer

Deb, Anuska and Mishra, Manshi and Kumar, Bimlesh and Kumar Pandey, Narendra and Singh, Saurabh and Singh Baghel,, Dileep and Mazumder, Rupa and Ji Porwal, Om (2024) Chemopreventive approach of Indian spice “Curcumin” in the treatment of breast cancer. Trends in Immunotherapy, 8 (1). ISSN 2573-5985

[img] Text (Research Article)
2211-12198-1-PB.pdf - Published Version

Download (620kB)
Official URL: https://systems.enpress-publisher.com/index.php/ti...

Abstract

One of the primary concerns for women in good health is breast cancer. The most typical hazardous growth is this one. It spreads easily, and the clinical conditions are terrible. Bosom illness is the second‐most common type of malignant tumor that regularly causes women to pass away in the U.S. bosom malignant growth is the most well‐known disease among women worldwide, with 2.1 million cases reported in 2018 and more than 620,000 fatalities per year. Natural components are viewed as promising alternatives for the development of novel anti‐tumor drugs. Curcumin, also termed diferuloylmethane, is a yellow pigment made by the turmeric plant, Curcuma longa Linn. It is the curcuminoid and polyphenol present in the plant’s root that is most abundant. The antioxidant and anti‐inflammatory qualities of curcumin have been demonstrated, and it is frequently utilized in traditional medicine and cuisine. Due to its sophisticated pharmacological capabilities of chemoprevention and anticancer effects, curcumin, the main component of turmeric, has been linked to the treatment of breast cancer. The morbidity or mortality of the disease have not been significantly decreased by current breast cancer treatment options such as surgery, radiation, adjuvant chemotherapy, or hormone therapy. The expansion, estrogen receptor (trauma center), and human epidermal development factor receptor 2 (HER2) pathways are all involved in the activity of curcumin in illness. In breast cancer cells, curcumin is also known to regulate microRNA, cell stage-related characteristics, and apoptosis. This study reviews recent research on the atomic targets and anticancer effects of curcumin in breast cancer.

Item Type: Article
Uncontrolled Keywords: curcumin; chemotherapy; breast cancer; HER2
Subjects: Q Science > QD Chemistry
Q Science > QK Botany
R Medicine > R Medicine (General)
R Medicine > RA Public aspects of medicine
R Medicine > RA Public aspects of medicine > RA0421 Public health. Hygiene. Preventive Medicine
R Medicine > RC Internal medicine > RC0254 Neoplasms. Tumors. Oncology (including Cancer)
R Medicine > RV Botanic, Thomsonian, and eclectic medicine
Depositing User: ePrints deposit
Date Deposited: 04 Sep 2024 13:57
Last Modified: 04 Sep 2024 13:57
URI: http://eprints.tiu.edu.iq/id/eprint/1574

Actions (login required)

View Item View Item